VIRTUS HEALTH LIMITED
stock AU:VRT (SYDNEY)

Alternative ID: AU000000VRT3

Watch List

Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!
  • Exchange: SYDNEY
  • Sector: Healthcare
  • Industry: Health Care Equipment & Services
  • Market Cap: Small (692.85M)
  • Data in AUD
  • EPS: 0.19
  • Current PE: 102.59
  • BVPS: 3.69
  • Price/BVPS: 5.37
  • Dividend: 0.12 / 1.5%
  • Hist Grade: C (60.76)
  • YOY Grade: E (27.11)
  • Debt/FCF: 1.86
  • ROIC: 10.0%
  • PEG: 54.28
  • PEGY: 30.43
  • Value Price: 1.32
  • MOS Price: 0.66
  • MOS %: -93.3%
  • Graham Number: 6.65
  • Graham MOS %: -66.4%
  • IRT: 49.99

Market Price

19.80 

0.40 2.1%

as of Jun 02 '23

52 Week Range:

7.60 20.53

Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

  • Exchange: SYDNEY
  • Sector: Healthcare
  • Industry: Health Care Equipment & Services
  • Market Cap: Small (692.85M)
  • Inst. Ownership: 98.61%
  • Insider Ownership: 0.00%
  • Full Time Employees: 1300
Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore. The company operates through two segments, Healthcare Services Australia and Healthcare Services International. It provides fertility services, medical day procedure services, and medical diagnostics and pathology services. It also offers in-vitro fertilization (IVF) services. In addition, the company offers medical day procedure services, such as gastroenterologists, colorectal surgeons, plastic surgeons, urologists, gynecologists, ophthalmologists, dental surgeons, hand surgeons, and other surgeons. As of August 23, 2021, it operated through a network of 128 fertility specialists supported by approximately 1300 professional staff. Virtus Health Limited was founded in 2008 and is headquartered in Greenwich, Australia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement


 

Cash Flow Statement


 

Balance Sheet


 

Liquidity Ratios

Current Ratio

 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '12 Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21
Equity (BVPS) 2.83
2.96
2.83
2.94
3.04
3.29
3.51
3.57
3.69
growth rate 4.6% -4.4% 3.9% 3.4% 8.2% 6.7% 1.7% 3.4%
Earnings BIT 40.00
51.37
49.95
53.68
47.46
50.25
47.02
40.60
67.15
growth rate 28.4% -2.8% 7.5% -11.6% 5.9% -6.4% -13.7% 65.4%
Avg.PE 38.46
21.19
14.03
19.61
15.07
15.36
11.37
586.67
29.64
growth rate -44.9% -33.8% 39.8% -23.2% 1.9% -26.0% 5,059.8% -95.0%
ROA 0.00
2.62
7.59
6.58
7.02
5.84
5.94
5.22
0.08
7.00
growth rate 189.7% -13.3% 6.7% -16.8% 1.7% -12.1% -98.5% 8,650.0%
ROE 8.74
0.00
4.60
13.95
12.89
14.13
11.53
11.79
10.20
0.17
15.23
growth rate -100.0% 203.3% -7.6% 9.6% -18.4% 2.3% -13.5% -98.3% 8,858.8%
ROIC 8.99
7.10
9.94
9.57
10.20
8.55
8.43
7.72
1.17
8.85
growth rate -11.1% 40.0% -3.7% 6.6% -16.2% -1.4% -8.4% -84.8% 656.4%
Cur. Ratio 0.72
1.10
1.04
0.94
1.06
0.90
0.78
0.66
0.62
0.69
growth rate 52.8% -5.5% -9.6% 12.8% -15.1% -13.3% -15.4% -6.1% 11.3%
Quick Ratio 0.72
1.00
1.00
0.90
0.98
0.83
0.70
0.59
0.57
0.62
growth rate 38.9% 0.0% -10.0% 8.9% -15.3% -15.7% -15.7% -3.4% 8.8%
Leverage 1.81
1.80
1.87
2.05
1.98
1.97
2.00
1.92
2.34
2.02
growth rate -0.6% 3.9% 9.6% -3.4% -0.5% 1.5% -4.0% 21.9% -13.7%
Balance Sheet Jun '12 Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21
Acct.Receivable 0.00
11.00
12.48
13.65
11.33
12.34
12.49
14.84
13.37
12.09
growth rate 13.4% 9.4% -17.0% 8.9% 1.2% 18.8% -9.9% -9.6%
Acct.Payable 6.00
7.00
10.28
10.33
10.04
8.88
10.34
8.40
12.34
11.07
growth rate 8.0% 46.9% 0.5% -2.8% -11.5% 16.5% -18.8% 47.0% -10.3%
Cur.Assets 13.60
25.00
35.51
33.80
36.03
42.87
37.99
37.81
55.97
54.97
growth rate 83.8% 42.1% -4.8% 6.6% 19.0% -11.4% -0.5% 48.0% -1.8%
Total Assets 372.40
385.00
429.78
465.25
473.19
489.91
545.38
544.34
626.42
605.31
growth rate 3.4% 11.6% 8.3% 1.7% 3.5% 11.3% -0.2% 15.1% -3.4%
Cash 1.50
12.00
21.50
18.37
22.22
27.34
21.71
18.83
38.05
37.01
growth rate 700.0% 79.2% -14.6% 20.9% 23.1% -20.6% -13.3% 102.0% -2.7%
Inventory 0.10
1.00
0.17
0.28
0.55
0.76
0.75
1.26
1.40
1.31
growth rate 900.0% -83.4% 67.5% 97.8% 37.8% -0.8% 67.0% 11.4% -6.2%
Cur.Liabilities 18.80
23.00
34.14
34.16
33.99
47.81
48.57
57.09
89.81
79.28
growth rate 22.3% 48.4% 0.1% -0.5% 40.7% 1.6% 17.5% 57.3% -11.7%
Liabilities 166.70
171.00
190.16
218.93
215.14
221.54
261.83
249.72
358.21
304.70
growth rate 2.6% 11.2% 15.1% -1.7% 3.0% 18.2% -4.6% 43.4% -14.9%
LT Debt 144.50
144.00
139.42
152.82
149.11
154.00
183.66
177.51
167.96
145.95
growth rate -0.4% -3.2% 9.6% -2.4% 3.3% 19.3% -3.4% -5.4% -13.1%
Equity 205.70
214.60
229.39
227.44
238.60
248.71
273.07
284.16
267.41
299.09
growth rate 4.3% 6.9% -0.9% 4.9% 4.2% 9.8% 4.1% -5.9% 11.9%
Common Shares 54.00
60.00
80.00
81.00
81.00
81.00
242.25
242.48
242.89
244.03
growth rate 5.4% 33.3% 1.3% 0.0% 0.0% 199.1% 0.1% 0.2% 0.5%
Cash Flow Statement Jun '12 Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21
Capital Expenditures 0.00
11.00
8.01
12.34
9.63
9.85
15.50
14.55
7.92
14.86
growth rate -27.2% 54.1% -22.0% 2.3% 57.4% -6.1% -45.6% 87.5%
Cash Dividends 0.00
74.60
9.45
21.30
22.10
22.51
20.90
19.29
9.65
19.29
growth rate -87.3% 125.5% 3.8% 1.8% -7.1% -7.7% -50.0% 100.0%
Cash From OA 29.00
28.00
52.54
40.84
47.69
38.71
54.97
38.29
66.38
65.82
growth rate -1.7% 87.7% -22.3% 16.8% -18.8% 42.0% -30.3% 73.4% -0.9%
FCF per Share 0.38
0.29
0.50
0.35
0.42
0.52
0.25
0.47
0.78
growth rate -23.7% 72.4% -30.0% 20.0% 23.8% -51.9% 88.0% 66.0%
Sale Purchase of Stock 1.06
0.99
0.12
3.17
growth rate -6.0% -87.7% 2,500.0%
FCF 21.00
17.00
45.00
28.00
38.00
29.00
39.00
24.00
58.00
51.00
growth rate -10.0% 164.7% -37.8% 35.7% -23.7% 34.5% -38.5% 141.7% -12.1%
Income Statement Jun '12 Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21
Sales 165.00
187.00
201.55
234.14
261.21
256.52
263.92
280.70
267.98
333.92
growth rate 6.5% 7.8% 16.2% 11.6% -1.8% 2.9% 6.4% -4.5% 24.6%
Op.Income 0.00
40.00
51.37
49.95
53.68
47.46
50.25
47.02
40.60
67.15
growth rate 28.4% -2.8% 7.5% -11.6% 5.9% -6.4% -13.7% 65.4%
IBT 0.00
14.40
43.84
42.48
49.09
42.83
44.86
40.17
10.43
60.40
growth rate 204.5% -3.1% 15.6% -12.8% 4.7% -10.5% -74.0% 479.0%
Net Income 0.00
10.00
30.89
29.43
32.92
28.10
30.75
28.43
0.47
43.14
growth rate 208.9% -4.7% 11.8% -14.6% 9.4% -7.6% -98.4% 9,097.2%
EPS 0.37
0.00
0.17
0.38
0.37
0.41
0.35
0.38
0.35
0.01
0.53
growth rate -100.0% 123.5% -2.6% 10.8% -14.6% 8.6% -7.9% -97.1% 5,200.0%
Gross Profit 72.00
74.00
84.95
92.52
100.44
96.49
100.94
102.95
95.20
123.69
growth rate 1.4% 14.8% 8.9% 8.6% -3.9% 4.6% 2.0% -7.5% 29.9%
R&D 2.70
3.40
growth rate 25.9%

Quarterly Statements

Item Name Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Earnings BIT 22.39
15.03
15.03
12.83
12.83
growth rate -32.9% 0.0% -14.6% 0.0%
Balance Sheet Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Acct.Receivable 10.93
12.09
12.09
12.12
12.12
growth rate 10.6% 0.0% 0.3% 0.0%
Acct.Payable 29.01
11.07
11.07
34.83
34.83
growth rate -61.8% 0.0% 214.6% 0.0%
Cur.Assets 54.02
54.97
54.97
38.60
38.60
growth rate 1.8% 0.0% -29.8% 0.0%
Total Assets 622.22
605.31
605.31
589.47
589.47
growth rate -2.7% 0.0% -2.6% 0.0%
Cash 37.11
37.01
37.01
18.48
18.48
growth rate -0.3% 0.0% -50.1% 0.0%
Inventory 1.36
1.31
1.31
1.54
1.54
growth rate -3.5% 0.0% 17.1% 0.0%
Cur.Liabilities 69.24
79.28
79.28
71.07
71.07
growth rate 14.5% 0.0% -10.4% 0.0%
Liabilities 325.55
304.70
304.70
249.16
249.16
growth rate -6.4% 0.0% -18.2% 0.0%
LT Debt 156.91
145.95
145.95
95.04
95.04
growth rate -7.0% 0.0% -34.9% 0.0%
Equity 295.48
299.09
299.09
338.65
338.65
growth rate 1.2% 0.0% 13.2% 0.0%
Common Shares 243.03
244.03
244.03
278.37
278.37
growth rate 0.4% 0.0% 14.1% 0.0%
Cash Flow Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Capital Expenditures 3.61
3.81
3.81
3.18
3.18
growth rate 5.5% 0.0% -16.7% 0.0%
Cash Dividends 4.82
4.82
4.82
5.13
5.13
growth rate 0.0% 0.0% 6.4% 0.0%
Cash From OA 16.05
16.86
16.86
10.35
10.35
growth rate 5.1% 0.0% -38.6% 0.0%
Sale Purchase of Stock
growth rate
FCF 12.44
13.05
13.05
7.18
7.18
growth rate 4.9% 0.0% -45.0% 0.0%
Income Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Sales 89.11
81.69
81.69
86.01
86.01
growth rate -8.3% 0.0% 5.3% 0.0%
Op.Income 22.39
15.03
15.03
12.83
12.83
growth rate -32.9% 0.0% -14.6% 0.0%
IBT 21.20
9.00
9.00
10.75
10.75
growth rate -57.5% 0.0% 19.4% 0.0%
Net Income 14.96
6.60
6.60
7.56
7.56
growth rate -55.9% 0.0% 14.5% 0.0%
Gross Profit 36.34
29.34
29.34
29.77
29.77
growth rate -19.3% 0.0% 1.5% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (60.76)

YOY Growth Grade:

E (27.11)

Click on buttons above for detailed yearly growth rates.

Market Ratios

  • Dividend Yield: 1.5%

  • Beta: 1.51

    Beta of 1.5079 suggests that the asset is more volatile than the rest of the market.

  • PE: 102.59

  • EY: 1.0%

  • PEG: 54.28

    PEG Ratio of 54.28 suggests that stock is overpriced.

  • PEGY: 30.43

    PEGY Ratio of 30.43 suggests that stock is overpriced.

  • Price/BVPS: 5.37

Profitability Ratios

  • ROE: 15.2%

    Return on Equity (ROE) of 15.2% suggests that a company is doing well.

  • ROS: 20.1%

    The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.

  • ROA: 10.0%

    Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.

  • ROI: 20.2%

    Return on Investment (ROI) of 20.2% suggests that a company is doing well.

  • ROIC: 10.0%

    Return on Invested Capital (ROIC) of 10.0% suggests that management is inefficient or it could reflect a highly capitalized, conservatively operated business with little long term debt.

Liquidity Ratios

  • Current Ratio: 0.69

    Current Ratio of 0.69 suggests that a company may not be able to pay off bills as rapidly as it should.

  • Quick Ratio: 0.62

    Quick Ratio of 0.62 suggests that a company does not have enough cash to cover immediate liabilities.

  • Cash Turnover: -13.74

    Turnover Of Cash Ratio of -13.74 suggests that a company may have funds tied up in short-term low-yielding assets or may have a cash surplus, which is not invested in the business.

  • Equity Ratio: 49.4%

    Equity Ratio of 49.4% suggests that a reasonably large percent of the company's assets financed by shareholder equity.

  • Debt/Equity: 101.9%

    Debt to Equity Ratio of 101.9% suggests that greater risk assumed by creditors, hence greater interest by them in the way the company is being managed.

  • Debt/FCF: 1.86

    Debt/FCF of 1.86 suggests that a company is doing well and can pay off its long term debt within three years.

Efficiency Ratios

  • Avg Collection Period: 13.21

    Average Collection Period of 13.21 days suggests that a company is doing well.

  • Inventory Turnover: 160.11

    Inventory Turnover Ratio of 160.11 suggests that a company is doing well.

  • Cash Flow Ratio: 1.21

    Cash Flow Ratio of 1.21 suggests a large inventory, a never-out-of-stock situation, perhaps some obsolete items, or slow cash flow in general - could indicate poor liquidity.

  • Profit Margin: 12.9%

Value Price

PE and EPS

Historical Current Forward
PE 41.97 102.59 17.23
EPS / Growth -4.9% 0.19 1.9%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 2.6% 2.6%
Future PE 2.00 21.46 21.46
Future EPS 0.21 0.25 0.25
Value Price
MOS %		 0.11
-99.5% 		1.32
-93.3% 		1.32
-93.3%
MOS Price 0.05 0.66 0.66
IRT 70.45 49.99 49.99

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

  • Graham Number: 6.65
  • Graham MOS: -66.4%

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.